Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition
eLife, ISSN: 2050-084X, Vol: 6
2017
- 220Citations
- 237Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations220
- Citation Indexes220
- 220
- CrossRef209
- Captures237
- Readers237
- 235
- Mentions1
- News Mentions1
- 1
Most Recent News
Environmental cystine drives glutamine anaplerosis and sensitizes cancer cells to glutaminase inhibition
Essential revisions: 1) Most of the work focuses on a single cell line to establish the mechanism for glutamine dependence. The authors should provide some
Article Description
Many mammalian cancer cell lines depend on glutamine as a major tri-carboxylic acid (TCA) cycle anaplerotic substrate to support proliferation. However, some cell lines that depend on glutamine anaplerosis in culture rely less on glutamine catabolism to proliferate in vivo. We sought to understand the environmental differences that cause differential dependence on glutamine for anaplerosis. We find that cells cultured in adult bovine serum, which better reflects nutrients available to cells in vivo, exhibit decreased glutamine catabolism and reduced reliance on glutamine anaplerosis compared to cells cultured in standard tissue culture conditions. We find that levels of a single nutrient, cystine, accounts for the differential dependence on glutamine in these different environmental contexts. Further, we show that cystine levels dictate glutamine dependence via the cystine/glutamate antiporter xCT/SLC7A11. Thus, xCT/SLC7A11 expression, in conjunction with environmental cystine, is necessary and sufficient to increase glutamine catabolism, defining important determinants of glutamine anaplerosis and glutaminase dependence in cancer.
Bibliographic Details
10.7554/elife.27713; 10.7554/elife.27713.002; 10.7554/elife.27713.026; 10.7554/elife.27713.032; 10.7554/elife.27713.011; 10.7554/elife.27713.003; 10.7554/elife.27713.020; 10.7554/elife.27713.001; 10.7554/elife.27713.015; 10.7554/elife.27713.016; 10.7554/elife.27713.031
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85029423845&origin=inward; http://dx.doi.org/10.7554/elife.27713; http://www.ncbi.nlm.nih.gov/pubmed/28826492; https://elifesciences.org/articles/27713#digest; http://dx.doi.org/10.7554/elife.27713.002; https://elifesciences.org/articles/27713#fig5; http://dx.doi.org/10.7554/elife.27713.026; http://dx.doi.org/10.7554/elife.27713.032; https://elifesciences.org/articles/27713; https://cdn.elifesciences.org/articles/27713/elife-27713-v2.pdf; https://cdn.elifesciences.org/articles/27713/elife-27713-v2.xml; https://elifesciences.org/articles/27713#fig2; http://dx.doi.org/10.7554/elife.27713.011; https://elifesciences.org/articles/27713#fig1; http://dx.doi.org/10.7554/elife.27713.003; https://elifesciences.org/articles/27713#fig4; http://dx.doi.org/10.7554/elife.27713.020; https://elifesciences.org/articles/27713#abstract; http://dx.doi.org/10.7554/elife.27713.001; https://elifesciences.org/articles/27713#table1; http://dx.doi.org/10.7554/elife.27713.015; https://elifesciences.org/articles/27713#fig3; http://dx.doi.org/10.7554/elife.27713.016; https://elifesciences.org/articles/27713#author-response; https://elifesciences.org/articles/27713#decision-letter; http://dx.doi.org/10.7554/elife.27713.031; https://dx.doi.org/10.7554/elife.27713
eLife Sciences Organisation, Ltd.
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know